Mega-Dose vitamin c trial offers hope for Tough-to-Treat blood cancer
NCT ID NCT03602235
Summary
This early-stage study tested whether adding very high doses of vitamin C (ascorbic acid) to a low dose of chemotherapy (melphalan) is safe and might help control advanced multiple myeloma. It involved 6 patients whose cancer had returned or stopped responding to multiple prior treatments. The main goal was to check for side effects while looking for early signs that the combination could reduce cancer levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.